Opportunistic Infections Citation List:
February 3 - February 16, 2010
OPPORTUNISTIC PROTOZOA COMPOUNDS (including pneumocystis, cryptosporidium, toxoplasma, microsporidia [encephalitozoon, enterocytozoon, vittaforma])
1. Dinitroaniline Activity in Toxoplasma gondii Expressing Wild-type or Mutant Alpha-Tubulin. Ma, C., J. Tran, F. Gu, R. Ochoa, C. Li, D. Sept, K. Werbovetz, and N. Morrissette. Antimicrob Agents Chemother. [Epub ahead of print]; PMID[20145086].
[Pubmed]. OI_0204-021610.
2.Parasiticidal activity of human alpha-defensin-5 against Toxoplasma gondii. Tanaka, T., M.M. Rahman, B. Battur, D. Boldbaatar, M. Liao, R. Umemiya-Shirafuji, X. Xuan, and K. Fujisaki. In Vitro Cell Dev Biol Anim. [Epub ahead of print]; PMID[20135360].
[Pubmed]. OI_0204-021610.
ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
3.Chemical synthesis and biological screening of 2-aminoimidazole-based bacterial and fungal antibiofilm agents. Rogers, S.A., J.D. Bero, and C. Melander. Chembiochem. 11(3): p. 396-410; PMID[20049758].
[Pubmed]. OI_0204-021809.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
4. Antimalarial and antitubercular nostocarboline and eudistomin derivatives: Synthesis, in vitro and in vivo biological evaluation. Bonazzi, S., D. Barbaras, L. Patiny, R. Scopelliti, P. Schneider, S.T. Cole, M. Kaiser, R. Brun, and K. Gademann. Bioorg Med Chem. 18(4): p. 1464-1476; PMID[20133138].
[Pubmed]. OI_0204-021610.
5. Synthesis and Antimycobacterial Evaluation of Novel Phthalazin-4-ylacetamides Against log- and Starved Phase Cultures. Sriram, D., P. Yogeeswari, P. Senthilkumar, D. Sangaraju, R. Nelli, D. Banerjee, P. Bhat, and T.H. Manjashetty. Chem Biol Drug Des. [Epub ahead of print]; PMID[20148903].
[Pubmed]. OI_0204-021610.
Citations from the ISI Web of Knowledge Listings for O.I.
6.Studies Toward the Synthesis of Inhibitors of Mycobacterium tuberculosis Cell-Wall Biosynthesis: The Assembly of Triazole-Linked 1,6-alpha-D-Oligomannosides via Click CuAAC. Lo Conte, M., A. Chambery, A. Marra, and A. Dondoni. Synlett, 2009(16): p. 2679-2681; ISI[000273766700026].
[WOS]. OI_0204-021610.
7.Characterising the post-antifungal effects of micafungin against Candida albicans, Candida glabrata, Candida parapsilosis and Candida krusei isolates. Nguyen, K.T., P. Ta, B.T. Hoang, S.J. Cheng, B.H. Hao, M.H. Nguyen, and C.J. Clancy. International Journal of Antimicrobial Agents. 35(1): p. 80-84; ISI[000273717800016].
[WOS]. OI_0204-021610.